Skip to main content
    C

    CVS Health Corp (CVS)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $92.54
    -0.93 (-0.99%)

    Market Cap: $119.55B

    Last updated: Oct 27, 2026 at 10:41 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(37/39)
    Avg Surprise
    +9.21%
    Streak
    7 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.65
    Range$1.52 - $1.87
    23 analysts
    EPS Revisions
    2
    0
    7d
    5
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$1.71-3.6%
    60d ago$1.64+0.8%
    30d ago$1.61+2.5%
    7d ago$1.63+1.4%
    Current$1.65
    Revenue Consensus
    $104.8B
    Range$102.3B - $108.9B
    18 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.33
    Range$2.23 - $2.44
    25 analysts
    Revenue Consensus
    $118.1B
    Range$114.2B - $127.4B
    21 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.33---
    Sep 26EST
    		-$1.65---
    Jun 26
    Reported Aug 5
    		$2.58$1.87+37.97%Beat+42.5%
    Mar 26
    Reported May 6
    		$2.57$2.21+16.29%Beat+14.2%
    Dec 25
    Reported Feb 10
    		$1.09$1.00+9.00%Beat-8.4%
    Sep 25
    Reported Oct 29
    		$1.60$1.36+17.65%Beat+46.8%
    Jun 25
    Reported Jul 31
    		$1.81$1.46+23.97%Beat-1.1%
    Mar 25
    Reported May 1
    		$2.25$1.67+34.73%Beat+71.8%
    Dec 24
    Reported Feb 12
    		$1.19$0.92+29.35%Beat-43.9%
    Sep 24
    Reported Nov 6
    		$1.09$1.46-25.34%Miss-50.7%
    Jun 24
    Reported Aug 7
    		$1.83$1.73+5.78%Beat-17.2%
    Mar 24
    Reported May 1
    		$1.31$1.70-22.94%Miss-40.5%
    Dec 23
    Reported Feb 7
    		$2.12$1.99+6.53%Beat+6.5%
    Sep 23
    Reported Nov 1
    		$2.21$2.13+3.76%Beat+2.8%
    Jun 23
    Reported Aug 2
    		$2.21$2.12+4.25%Beat-7.9%
    Mar 23
    Reported May 3
    		$2.20$2.09+5.26%Beat-0.9%
    Dec 22
    Reported Feb 8
    		$1.99$1.93+3.11%Beat+0.5%
    Sep 22
    Reported Nov 2
    		$2.15$1.99+8.04%Beat+9.1%
    Jun 22
    Reported Aug 3
    		$2.40$2.18+10.09%Beat-0.8%
    Mar 22
    Reported May 4
    		$2.22$2.15+3.26%Beat+8.8%
    Dec 21
    Reported Feb 9
    		$1.98$1.88+5.32%Beat+52.3%
    Sep 21
    Reported Nov 3
    		$1.97$1.79+10.06%Beat+18.7%
    Jun 21
    Reported Aug 4
    		$2.42$2.07+16.91%Beat-8.3%
    Mar 21
    Reported May 4
    		$2.04$1.72+18.60%Beat+6.8%
    Dec 20
    Reported Feb 16
    		$1.30$1.24+4.84%Beat-24.9%
    Sep 20
    Reported Nov 6
    		$1.66$1.34+23.88%Beat-9.8%
    Jun 20
    Reported Aug 5
    		$2.64$1.92+37.50%Beat+39.7%
    Mar 20
    Reported May 6
    		$1.91$1.63+17.18%Beat+17.9%
    Dec 19
    Reported Feb 12
    		$1.73$1.69+2.37%Beat-19.2%
    Sep 19
    Reported Nov 6
    		$1.84$1.77+3.95%Beat+6.4%
    Jun 19
    Reported Aug 7
    		$1.89$1.69+11.83%Beat+11.8%
    Mar 19
    Reported May 1
    		$1.62$1.51+7.28%Beat+9.5%
    Dec 18
    Reported Feb 20
    		$2.14$2.05+4.39%Beat+11.5%
    Sep 18
    Reported Nov 6
    		$1.73$1.71+1.17%Beat+15.3%
    Jun 18
    Reported Aug 8
    		$1.69$1.61+4.97%Beat+27.1%
    Mar 18
    Reported May 2
    		$1.48$1.41+4.96%Beat+26.5%
    Dec 17
    Reported Feb 8
    		$1.92$1.88+2.13%Beat+12.3%
    Sep 17
    Reported Nov 6
    		$1.50$1.49+0.67%Beat-
    Jun 17
    Reported Aug 8
    		$1.33$1.31+1.53%Beat-
    Mar 17
    Reported May 2
    		$1.17$1.10+6.36%Beat-
    Dec 16
    Reported Feb 9
    		$1.71$1.67+2.40%Beat-

    Dividends

    Dividend Metrics

    Forward Yield2.87%
    Forward Annual Dividend$2.66
    Payout Ratio23.02%
    FrequencyQuarterly
    Pay MonthsFeb, May, Aug, Nov

    Growth

    3Y CAGR+6.53%
    5Y CAGR+5.87%
    CVS dividend history and ex-dividend datesRun CVS in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio11.80EV/EBITDA14.03x
    Price/FCF10.07xFCF Yield9.93%
    Profitability
    Profit Margin1.18%Operating Margin3.86%
    ROE6.21%ROIC4.60%
    Financial Health
    Debt/Equity0.93xInterest Coverage2.71x
    Current Ratio0.87xQuick Ratio0.66x
    Trading Statistics
    Beta0.60Avg Volume8.53M
    52-Week High$109.2252-Week Low$67.99

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$91.97
    SMA 20$89.06
    SMA 50$90.92
    SMA 200$87.73
    EMA 10$91.90
    EMA 20$90.71
    EMA 50$91.48
    EMA 200$88.38

    MACD

    Line: 0.92Signal: 0.09Hist: 0.83

    ADX

    ADX: 22.2+DI: 23.4-DI: 20.8

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down32.0
    PSAR$90.95

    Bollinger Bands

    Upper Band$95.89
    Lower Band$82.23
    %B Position1534%(Upper)
    Band Width0.75

    RSI (14-Day)

    Neutral
    56.1

    Momentum Oscillators

    Stoch %K81.6
    Stoch %D83.7
    Williams %R-28.8
    ROC (10d)6.2%
    Momentum5.41
    CCI (20d)83.3
    MFI (14d)65.2

    Volatility Measures

    ATR (14d)$2.36(2.6%)
    StdDev (20d)3.42
    Hist Vol24.1%(Moderate)

    Volume Flow

    VWAP$93.11
    OBV215.6M
    AD Line-3.2B
    CMF (20d)-0.511

    Volume Metrics

    Avg Vol (20d)8.6M
    Vol Ratio0.5x(Low)
    VWMA (20d)$88.59

    Pivot Points

    R3$95.36
    R2$94.88
    R1$94.17
    Pivot Point$93.69
    S1$92.99
    S2$92.51
    S3$91.81

    Advanced Oscillators

    TSI10.60
    Ultimate Osc35.2
    KST15.88

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$106.10B$100.43B$105.69B$102.87B$98.92B$94.59B$97.71B$95.43B$91.23B$88.44B$93.81B$89.76B
    Cost of Revenue$58.86B$55.44B$59.06B$57.05B$54.01B$51.06B$55.27B$52.95B$50.00B$48.07B$36.97B$54.69B
    Gross Profit$47.23B$44.98B$46.63B$45.83B$44.91B$43.53B$42.44B$42.48B$41.24B$40.36B$56.84B$35.08B
    Operating Expenses$42.53B$40.30B$44.52B$49.03B$42.53B$40.16B$40.07B$41.65B$38.19B$38.09B$53.47B$31.39B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$11.05B$10.94B$11.46B$11.29B$11.21B$11.02B$10.52B$10.56B$10.34B$10.29B$10.50B$9.88B
    Operating Income$4.70B$4.68B$2.11B$-3,207,000,000$2.38B$3.37B$2.37B$832.00M$3.04B$2.27B$3.37B$3.69B
    Interest Income$0$0$0$483.00M$0$0$0$0$0$0$0$0
    Interest Expense$757.00M$774.00M$787.00M$784.00M$763.00M$785.00M$267.00M$752.00M$732.00M$716.00M$690.00M$693.00M
    Income Before Tax$3.98B$3.94B$1.35B$-3,482,000,000$1.65B$2.62B$2.13B$105.00M$2.34B$1.58B$2.71B$3.02B
    Income Tax Expense$982.00M$981.00M$-1,569,000,000$508.00M$634.00M$835.00M$503.00M$34.00M$569.00M$456.00M$658.00M$754.00M
    Net Income$3.00B$2.96B$2.92B$-3,990,000,000$1.01B$1.78B$1.62B$71.00M$1.77B$1.12B$2.05B$2.27B
    EBITDA$5.86B$5.83B$3.29B$-2,047,000,000$3.58B$4.56B$3.54B$2.02B$4.22B$3.43B$4.53B$4.84B
    EBIT$4.73B$4.71B$2.14B$-3,181,000,000$2.41B$3.40B$2.39B$857.00M$3.07B$2.30B$3.40B$3.71B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    I Tested One Of Wall Street’s Favorite AI Trades - It Failed

    Travelers Q2 core income $10.04 vs $5.41 consensus, stock +10%; CEO credited AI for a 0.5 percentage-point improvement in underlying loss ratio while expense ratio rose to 29%. Wall Street thesis posits AI cuts SG&A to create EPS torque in low-margin giants - e.g....

    Leo Nelissen
    •
    8/2/26
    •
    256
    AI Stocks
    Also mentions:
    TRVCVSKRWMTUNH

    Health Insurer Stocks: Recent Crash is Likely An Attractive Buffett Style "Fat Pitch" Opportunity

    Monday Jan 27th was "The Monday night massacre" when Medicare announced a 0.7% increase in reimbursement rates for 2026. 5% to 6% was the consensus and health insurance companies fell between 8% and 20% in overnight trading. Only Humana has continued to decline (-26% so far) but Morningstar (and I)...

    Adam Galas
    •
    1/29/26
    •
    332
    value investing, Income, Value, Dividend Growth, Dividend Investing
    Also mentions:
    ELVCVSHUM

    Government Contracts

    Gov Obligations (TTM)
    $4.48M
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    258.2%
    Active Awards
    6
    New Awards (TTM)
    3
    Avg Remaining Term
    2.1 mo

    Top agency: Department of Health and Human Services at 99.1% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75F40125F19002Department of Health and Human ServicesFood and Drug Administration$5.48MSep 29, 2025
    36C25926N0296Department of Veterans AffairsDepartment of Veterans Affairs$204000Apr 2, 2026
    36C25925P0636Department of Veterans AffairsDepartment of Veterans Affairs$200000Apr 2, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Cardinal Health stock trades at EUR 226.05 with USD 58.2 billion value

    Cardinal Health's stock is trading at EUR 226.05, reflecting a USD 58.2 billion market capitalization and a 52-week range of USD 161.36-259.21. The company recently extended its distribution agreement with CVS through...

    ad-hoc-news.de•10/27/26•Somewhat-Bullish

    CSV Q3'26 Earnings: EPS estimate is 0.79 USD

    Carriage Services, Inc. (CSV) is projected to report its Q3'26 earnings on October 28th, with an estimated revenue of $109.47 million and earnings per share (EPS) of $0.79. This article provides a historical comparison...

    TradingView•10/27/26•Neutral

    CVS Health schedules November 4 results. CVS Health stock sits 16.39 percent below its 52-week high

    CVS Health has scheduled its third-quarter earnings call for November 4, 2026. The company recently reported a 7.30% year-over-year revenue increase to USD 106.10 billion in the second quarter and raised its full-year...

    ad-hoc-news.de•10/27/26•Somewhat-Bullish

    Q3 profit rose from $24.7M at Phillips Edison (PECO), alongside $181.8M in acquisitions.

    Phillips Edison & Company (PECO) reported a significant increase in third-quarter 2026 net income attributable to stockholders...

    Stock Titan•10/26/26•Somewhat-Bullish

    GLP-1 affordability: CVS Caremark’s approach to cost, access and weight management

    CVS Caremark is addressing the growing demand for GLP-1 therapies by combining medication access with personalized support programs to ensure affordability and long-term success. Recent research shows employers are...

    CVS Health•10/26/26•Somewhat-Bullish

    CVS Valuation and Fair Value

    P/E
    11.8x
    Forward P/E
    10.7x
    EV/EBITDA
    14.0x
    P/FCF
    10.1x
    PEG
    0.2x
    P/B
    1.5x
    See GNG's fair value

    CVS Profitability: Margins, ROIC and FCF

    Gross margin
    44.5%
    Operating margin
    3.9%
    Net margin
    1.2%
    ROIC
    4.6%
    ROE
    6.2%
    FCF yield
    9.9%

    CVS Competitors

    CompanyTicker
    Medtronic PLCMDT
    Stryker CorporationSYK
    Bristol-Myers Squibb CompanyBMY
    McKesson CorporationMCK
    Vertex Pharmaceuticals IncVRTX
    GlaxoSmithKline PLC ADRGSK
    Intuitive Surgical IncISRG
    HCA Healthcare, Inc.HCA

    Sector: Healthcare

    CVS Analyst Ratings

    Consensus
    Buy
    Analysts
    27
    Strong Buy
    7
    Buy
    18
    Hold
    2
    Sell
    0
    Strong Sell
    0

    CVS Bull Case vs Bear Case

    Bull case

    • CVS beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 92.6% of CVS's analyst ratings are Buy or Strong Buy.

    CVS Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    18.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.65
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    5 up, 1 down

    CVS Dividend

    Forward yield
    2.9%
    Payout ratio
    23.0%
    3Y DPS growth
    6.5%
    5Y DPS growth
    5.9%
    Pay months
    Feb, May, Aug, Nov
    CVS dividend history

    Frequently Asked Questions About CVS

    What is CVS's current dividend yield?

    CVS Health Corp (CVS) has a forward dividend yield of 2.87%.

    Does CVS pay dividends?

    Yes, CVS Health Corp pays dividends with a forward dividend yield of 2.87%.

    What is CVS's P/E ratio?

    CVS Health Corp has a price-to-earnings (P/E) ratio of 11.80.

    What is CVS's market cap?

    CVS Health Corp (CVS) has a market capitalization of $119.55B with a current stock price of $92.54.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In